Share this article and save a life!
For my non-radiology colleagues, which nodule is which is worrisome? A or B? Lung cancer found early, 10mm or less, improves long-term survival, per Dr. Henschke’s most recent study.
“What we present here is the 20-year follow-up on participants in our screening program that were diagnosed with lung cancer and subsequently treated,” Dr. Claudia Henschke of Icahn School of Medicine at Mount Sinai
“The key finding is that even after this long a time interval they are not dying of their lung cancer.”
The study found that the 20-year survival rate was 80% for the 1,285 I-ELCAP participants who were diagnosed with early-stage lung cancer. The survival rate for both the 139 participants with nonsolid cancerous lung nodules and the 155 participants with nodules of part-solid consistency was 100%.
For the 991 participants with solid nodules, the survival rate was 73%. Lung cancer survival for clinical Stage IA participants was 86%, regardless of consistency. For participants with pathologic Stage IA cancers of 10 mm or less, the 20-year survival rate was 92%.
The findings demonstrate the importance of routine and early screening.
“Ultimately, anyone interested in being screened needs to know that if they are unfortunate enough to develop lung cancer, that it can be cured if found early,” Dr. Henschke said.
For those of you playing along, A is the worrisome nodule with the spiculated margins.
A=Malignant, cancer
B=Benign, probably a lymph node
Improving lung cancer screening efficiency and compliance for all patients is the Oatmeal Health mission. With a new #HEDIS measure on the horizon from NCQA, we would like to help FQHCs be prepared.
We are ready to help. Please send jonathan@oatmealhealth.com a note if you’d like to learn more about Oatmeal Health.
#primarycare #radiology #lungcancerscreening #FQHC
Link to #RSNA article: https://lnkd.in/g6XpWh2d
Radiological Society of North America (RSNA)
Co-Authors:
David Yankelevitz, M.D.
Daniel M. Libby
James Smith, M.D.
Mark Pasmantier, M.D.
Rowena Yip, MPH
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
